Blujepa Tablet, Film Coated
Product Images NDC 0173-0922

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Blujepa (NDC 0173-0922). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gepotidacin Mesylate Dihydrate Chemical Structure (Blujepa Spl Graphic 01)

FDA Label Image

Blujepa Tablet 20 Count Label (Blujepa Spl Graphic 02)

Blujepa Tablet 20 Count Label (Blujepa Spl Graphic 02)
Store the medication at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F), as per USP guidelines. Each tablet contains 750 mg of gepotidacin. Keep tablets out of reach of children and do not accept if the safety seal is missing or broken. This medication is prescription-only and should be stored at Controlled Room Temperature. Reach out for product information or visit the given website for more details. Made in Belgium.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.